Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Abroad (travel likely)RecruitingPHASE2
Conditions
Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM · Glioblastoma Multiforme (GBM) · Glioma · Central Nervous System Diseases · Brain Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
- Highlands Oncology Group, Springdale, Arkansas, United States
- Columbia University Irving Medical Center, New York, New York, United States
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States